Experimental and Therapeutic Medicine

Scope & Guideline

Illuminating the path to medical breakthroughs and novel discoveries.

Introduction

Welcome to the Experimental and Therapeutic Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Experimental and Therapeutic Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1792-0981
PublisherSPANDIDOS PUBL LTD
Support Open AccessNo
Country-
TypeJournal
Convergefrom 2010 to 2018 (coverage discontinued in Scopus)
AbbreviationEXP THER MED / Exp. Ther. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPOB 18179, ATHENS 116 10, GREECE

Aims and Scopes

The journal 'Experimental and Therapeutic Medicine' is dedicated to publishing high-quality research focused on experimental and therapeutic advancements across various medical fields. Its key aims include promoting innovative research, enhancing therapeutic strategies, and advancing the understanding of disease mechanisms.
  1. Experimental Therapeutics:
    The journal emphasizes studies that explore novel therapeutic approaches, drug development, and clinical applications, focusing on both preclinical and clinical research.
  2. Molecular and Cellular Mechanisms:
    Research detailing the molecular and cellular pathways involved in disease processes is a core focus, providing insights into potential therapeutic targets.
  3. Translational Medicine:
    The journal promotes research that bridges laboratory findings with clinical applications, aiming to translate scientific discoveries into effective treatments.
  4. Interdisciplinary Approaches:
    It encourages interdisciplinary research that integrates various scientific domains, including pharmacology, biochemistry, and clinical medicine, to address complex health issues.
  5. Public Health and Epidemiology:
    Research addressing public health concerns, epidemiological studies, and the implications of disease on population health is also featured, reflecting the journal's commitment to broader health impacts.
In recent years, 'Experimental and Therapeutic Medicine' has seen a rise in specific research themes, reflecting current trends and emerging areas of interest in the medical field.
  1. Ferroptosis and Cell Death Mechanisms:
    Research on ferroptosis, a form of regulated cell death, has gained traction, highlighting its implications in various diseases, including cancer and neurodegeneration.
  2. MicroRNA and Long Non-Coding RNA Research:
    There is an increasing focus on the roles of microRNAs and long non-coding RNAs in disease mechanisms, particularly in cancer and metabolic disorders, as potential biomarkers and therapeutic targets.
  3. Immunotherapy and Targeted Treatments:
    Studies exploring immunotherapy approaches and targeted therapies for various cancers have surged, reflecting a growing interest in personalized medicine.
  4. Gut Microbiome and Health:
    Research investigating the gut microbiota's influence on various health conditions, including metabolic diseases and autoimmune disorders, is becoming a prominent theme in the journal.
  5. Neuroinflammation and Neurodegeneration:
    The relationship between neuroinflammation and neurodegenerative diseases is increasingly being explored, with a focus on identifying therapeutic strategies to mitigate these processes.

Declining or Waning

While the journal has consistently focused on various innovative medical research topics, certain themes have shown a decline in prominence in recent publications. This may reflect evolving research interests or shifts in clinical priorities.
  1. Traditional Herbal Medicine:
    There has been a noticeable decrease in the publication of studies focusing exclusively on traditional herbal medicine and its applications, as the emphasis shifts towards more contemporary and scientifically validated therapeutic approaches.
  2. Basic Science without Clinical Relevance:
    Research articles that focus heavily on basic science without clear clinical implications or applications have become less frequent, indicating a trend toward more clinically relevant studies.
  3. Single-Pathway Studies:
    There is a decline in studies that explore the effects of treatments on isolated pathways, with a growing preference for research that examines broader, multi-target approaches to therapy.
  4. Case Reports:
    The number of individual case reports has diminished, as the journal increasingly favors larger cohort studies and systematic reviews that provide more comprehensive insights into treatments and outcomes.
  5. Narrowly Focused Epidemiological Studies:
    Epidemiological studies that lack comprehensive data or broader contextual analysis are appearing less frequently, as there is a shift toward studies that address multifactorial influences on health outcomes.

Similar Journals

Animal Models and Experimental Medicine

Advancing biomedical research through innovative animal models.
Publisher: WILEYISSN: 2096-5451Frequency: 6 issues/year

Animal Models and Experimental Medicine is a prestigious open-access journal published by WILEY that has been a significant contribution to the field of biomedical research since its inception in 2018. Focusing on the role of animal models in the exploration of experimental medicine, the journal has garnered attention for its rigorous peer-reviewed articles that bridge laboratory research with clinical applications. The journal currently holds impressive quartile rankings, including Q1 in Medical Laboratory Technology, Veterinary (miscellaneous), and strong standings across various other categories, reflecting its reputable position within the Scopus rankings. With a commitment to disseminating high-quality research that advances knowledge and practice in veterinary and medical sciences, Animal Models and Experimental Medicine offers a platform for researchers, professionals, and students to contribute to and stay informed about pivotal developments in the field. As an open-access journal, it ensures accessibility, encouraging a wider readership and fostering collaboration among the scientific community.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Advancing the Frontiers of Drug Discovery and Therapeutics
Publisher: AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICSISSN: 0022-3565Frequency: 12 issues/year

The JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, published by the American Society for Pharmacology and Experimental Therapeutics, stands as a pivotal platform in the fields of pharmacology and molecular medicine. With an impressive convergence of knowledge from 1945 to 2024, this esteemed journal is recognized for its rigorous peer-reviewed research, contributing significantly to our understanding of drug action and therapeutic interventions. It holds a commendable position in the Q2 quartile in both Molecular Medicine and Pharmacology, emphasizing its relevance and impact within the contemporary scientific landscape, as evidenced by its Scopus ranking that places it amongst the leading journals in its category. Aimed at researchers, professionals, and students, the journal not only fosters a deeper insight into toxicology, pharmacodynamics, and therapeutic strategies but also encourages innovation through its comprehensive access to groundbreaking experimental methodologies. The journal continues to foster discourse and disseminate research that shapes the future of pharmacological science.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Empowering Researchers with Open Access Knowledge
Publisher: WILEYISSN: 1582-1838Frequency: 12 issues/year

Journal of Cellular and Molecular Medicine, published by Wiley, stands at the forefront of research excellence in the fields of cell biology and molecular medicine. With an impressive impact factor reflected in its 2023 Q2 category ranking for both Cell Biology and Molecular Medicine, this journal provides a vital platform for researchers and professionals alike, fostering innovative findings and groundbreaking discoveries since its inception in 2000. Maintaining an open access policy since 2012, the journal ensures that knowledge is freely disseminated, promoting collaboration and progress across the scientific community. With robust rankings in the Scopus database, including a position within the top 85th percentile in Molecular Medicine, the journal remains committed to advancing understanding of cellular functions and their implications in health and disease. Researchers, professionals, and students will find a treasure of high-quality articles and reviews that not only catalyze academic dialogue but also contribute significantly to practical applications in the life sciences.

INDIAN JOURNAL OF PHARMACOLOGY

Exploring the frontiers of pharmacology since 1978.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0253-7613Frequency: 6 issues/year

INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.

BIOMEDICAL RESEARCH-TOKYO

Advancing Biomedical Knowledge Since 1980
Publisher: BIOMEDICAL RESEARCH PRESS LTDISSN: 0388-6107Frequency: 6 issues/year

BIOMEDICAL RESEARCH-TOKYO is an esteemed interdisciplinary journal published by BIOMEDICAL RESEARCH PRESS LTD, dedicated to disseminating pioneering research and advancements in the fields of biochemistry, genetics, and medicine. Since its inception in 1980, the journal has established itself as a reputable source of knowledge, contributing significantly to the global scientific community with its strong emphasis on innovative findings and methodologies. With a consistent presence in the Q3 quartile for both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023, it continues to attract a diverse range of research articles. While the journal does not operate as an open access platform, it remains an essential resource for researchers, professionals, and students seeking to further their understanding of biomedical sciences. Located in Sapporo, Japan, this journal fosters collaboration and knowledge sharing among the international biomedical research community, engaging readers through its compelling studies that span from 1980 to 2024.

Journal of Translational Medicine

Pioneering the Path from Lab to Life.
Publisher: BMCISSN: Frequency: 1 issue/year

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

EXPERIMENTAL BIOLOGY AND MEDICINE

Bridging disciplines to enhance understanding of health and disease.
Publisher: FRONTIERS MEDIA SAISSN: 1535-3702Frequency: 18 issues/year

EXPERIMENTAL BIOLOGY AND MEDICINE is a distinguished open-access journal published by FRONTIERS MEDIA SA, specializing in the interdisciplinary fields of biochemistry, genetics, and medicine. With an ISSN of 1535-3702 and an E-ISSN of 1535-3699, this journal presents a robust platform for cutting-edge research and innovative clinical studies. Since its inception in 1996, it has evolved to feature a broad scope that caters to the evolving needs of researchers, professionals, and students, ensuring a dynamic dissemination of knowledge in biological and medical sciences. In 2023, the journal achieved a notable Q2 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, reflecting its strong impact and relevance within the academic community, as supported by its Scopus rank of #59 out of 221 in general biochemistry and genetics, placing it in the 73rd percentile. By offering open access options, EXPERIMENTAL BIOLOGY AND MEDICINE aims to maximize the reach and visibility of research findings, fostering collaboration and knowledge sharing across global audiences. Researchers are encouraged to contribute to this vital resource as it continues to advance the understanding of biological mechanisms and therapeutic approaches crucial for modern medicine.

MedComm

Fostering Collaboration in Cutting-Edge Medical Research
Publisher: WILEYISSN: Frequency: 4 issues/year

MedComm is a distinguished Open Access journal published by Wiley, located in the United States. Since its inception in 2020, it has rapidly established itself as a leading platform for cutting-edge research in the fields of Biochemistry, Cell Biology, Drug Discovery, Genetics, Immunology and Allergy, and Oncology, achieving a prestigious Q1 category ranking across multiple disciplines in 2023. MedComm is committed to providing a rigorous and transparent peer-review process, ensuring the publication of high-quality articles that advance the frontiers of medical science. With its remarkable Scopus ranking, the journal serves as an invaluable resource for researchers, professionals, and students looking to stay abreast of important developments in the life sciences. The open access model facilitates widespread dissemination of scholarly work, fostering collaboration and innovation within the global scientific community. Researchers interested in submitting their work or exploring the latest findings are encouraged to engage with this pivotal journal during the converged years from 2020 to 2024.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Pioneering Insights in Biochemistry, Genetics, and Medicine
Publisher: SPRINGERISSN: 0007-4888Frequency: 12 issues/year

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

Advances in Clinical and Experimental Medicine

Championing Open Access to Medical Excellence
Publisher: WROCLAW MEDICAL UNIVISSN: 1899-5276Frequency: 12 issues/year

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.